To further confirm the role of the PI3K/AKT/mTOR/HIF-1α signaling pathway in TGFBI-mediated tumor promotion, we used the AKT activator SC79 to treat 786-O cells transfected with TGFBI siRNA. Here, AKT1 is linked to neoplasm.